FindTrial
Sign In

"Enhancing Pain Relief: Combining Midazolam with Bupivacaine for Better Nerve Block Results"

"Assessing the Efficacy of Midazolam as an Adjuvant to Bupivacaine in Supraclavicular Brachial Plexus Block: A Clinical Evaluation" - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/074959
Enrollment
60
Registered
2024-10-08
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Supraclavicular brachial plexus block: USG guided Supraclavicular brachial plexus block using sterile high frequency probe on the ipsilateral side of the surgery, using 50 mmm block nee

Sponsors

Dr Abhinetri Madinkar
Lead Sponsor
ESICMC and PGIMSR
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: ASA I & II patients of either gender. Patients scheduled for elective or emergency surgeries on the forearm or hand

Exclusion criteria

Exclusion criteria: 1. Patients with bleeding disorders. 2. Patients receiving anticoagulants. 3. Patients on chronic analgesic therapy. 4. Patients with contralateral hemidiaphragmatic paralysis/extensively diseased lung. 5. Patients with h/o allergy to the study drugs.

Design outcomes

Primary

MeasureTime frame
To evaluate the quality of block with respect to the onset & duration of sensory and motor block. Timepoint: Immediately—

Secondary

MeasureTime frame
1.To assess total requirement of rescue analgesics in first 24 hours. 2.To assess any side effects. Timepoint: First 24 hrs.—

Countries

India

Contacts

Public ContactDr R Deepak

ESICMC and PGIMSR

deepakrkarnataka@gmail.com9482049960

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026